Media headlines about Intuitive Surgical (NASDAQ:ISRG) have been trending somewhat positive recently, Accern Sentiment reports. Accern rates the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Intuitive Surgical earned a news impact score of 0.20 on Accern’s scale. Accern also gave news coverage about the medical equipment provider an impact score of 45.5782369481768 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Here are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:
- Intuitive Surgical (ISRG) Stock Rating Reaffirmed by Barclays (americanbankingnews.com)
- Intuitive Surgical Stock Price and Research (Nasdaq: ISRG) (investmentu.com)
- Why This Auris Health Robot Won’t Replace Human Surgeons (edgylabs.com)
- Charting the Intuitive Surgical, Inc. (ISRG): does technical analysis work? (wallstreetmorning.com)
- This Morning’s Technical Outlook on Medical Equipment Stocks — Boston Scientific, Hologic, Intuitive Surgical, and … (prnewswire.com)
A number of equities research analysts have commented on ISRG shares. Zacks Investment Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating and set a $437.00 price objective for the company in a research report on Tuesday, December 12th. BidaskClub lowered Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, December 12th. ValuEngine lowered Intuitive Surgical from a “hold” rating to a “sell” rating in a research report on Friday, December 29th. Evercore ISI started coverage on Intuitive Surgical in a research report on Wednesday, January 3rd. They set an “in-line” rating and a $380.00 price objective for the company. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $410.00 price objective on shares of Intuitive Surgical in a research report on Friday, January 5th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $413.84.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, January 25th. The medical equipment provider reported $2.54 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.27 by $0.27. Intuitive Surgical had a return on equity of 19.93% and a net margin of 21.09%. The business had revenue of $892.40 million for the quarter, compared to the consensus estimate of $866.54 million. During the same period last year, the business earned $2.03 EPS. The firm’s revenue was up 17.9% compared to the same quarter last year. equities research analysts expect that Intuitive Surgical will post 7.85 EPS for the current year.
In related news, CEO Gary S. Guthart sold 28,525 shares of the firm’s stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $414.50, for a total value of $11,823,612.50. Following the transaction, the chief executive officer now directly owns 311,469 shares of the company’s stock, valued at approximately $129,103,900.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Mark J. Meltzer sold 24,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $433.00, for a total value of $10,392,000.00. Following the completion of the transaction, the senior vice president now directly owns 34,052 shares in the company, valued at $14,744,516. The disclosure for this sale can be found here. Insiders sold a total of 102,770 shares of company stock worth $43,410,836 over the last three months. 2.20% of the stock is owned by company insiders.
COPYRIGHT VIOLATION NOTICE: “Intuitive Surgical (ISRG) Earns Media Impact Rating of 0.20” was first published by BBNS and is owned by of BBNS. If you are reading this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this piece of content can be accessed at https://baseballnewssource.com/2018/03/29/somewhat-favorable-press-coverage-somewhat-unlikely-to-affect-intuitive-surgical-isrg-share-price/1968832.html.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.